Skip to Main Content

An official website of the United States government

Government Funding Lapse

Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit  cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at OPM.gov.

About this Publication
Title
Imaging Biomarker Discovery for Lung Cancer Survival Prediction
Digital Object Identifier
Publication
MICCAI 2016. 2016 Oct 2; Volume 9901: Pages pp 649-657
Authors
Jiawen Yao , Sheng Wang , Xinliang Zhu , Junzhou Huang
Abstract

Solid tumors are heterogeneous tissues composed of a mixture of cells and have special tissue architectures. However, cellular heterogeneity, the differences in cell types are generally not reflected in molecular profilers or in recent histopathological image-based analysis of lung cancer, rendering such information underused. This paper presents the development of a computational approach in H&E stained pathological images to quantitatively describe cellular heterogeneity from different types of cells. In our work, a deep learning approach was first used for cell subtype classification. Then we introduced a set of quantitative features to describe cellular information. Several feature selection methods were used to discover significant imaging biomarkers for survival prediction. These discovered imaging biomarkers are consistent with pathological and biological evidence. Experimental results on two lung cancer data sets demonstrated that survival models bsuilt from the clinical imaging biomarkers have better prediction power than state-of-the-art methods using molecular profiling data and traditional imaging biomarkers.

Related CDAS Studies
Related CDAS Projects